From : Jolene Engelbrecht (Contractor) <Jolene.Engelbrecht@gilead.com>
To : Sopo Belkania;Sean Barr <Sean.Barr@gilead.com>; Aysan Murtezaoglu <Aysan.Murtezaoglu@gilead.com>; Mariana Mkurnali
Subject : Slight time change to Epclusa supply call
Cc : Graeme Robertson <Graeme.Robertson@gilead.com>
Received On : 15.06.2018 14:52
Attachments :

Dear All,

 

Apologies, we will need to delay the start of this call by 30 minutes.

Unfortunately Graeme has been called to a meeting, but is able to start the call at 16h30.

 

Once again, apologies for this change.

 

I am sending the meeting notice update now.

 

Best wishes

Jolene

 

 

Jolene Engelbrecht

Senior Admin

Access Operations & Emerging Markets

 

cid:image002.png@01D3A571.5ABC6560

 

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd • Registered as a limited company in England and Wales • Registered number 05510315

Registered office: South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone: +44(0)208 587 2648 • Mobile: +44(0)770 44 55 880

 

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England